• The Bulgarian Drug Agency issues a new marketing authorisation for the medicinal product Remifentanil-Tchaikapharma used in hospitals

    January 4, 2016

    The Bulgarian Drug Agency has issued a marketing authorisation for the medicinal product Remifentanil-Tchaikapharma 1 mg, 5 mg powder for concentrate for solution for injection/infusion, containing the active substance remifentanil and belonging to a group of medicines known as opiates.

    Remifentanil-Tchaikapharma is used together with other medicines called anaesthetics to:

    • Facilitate falling asleep before surgery;
    • Put to sleep the patient and prevent the feeling of pain during surgery;
    • Cause drowsiness and prevent the feeling of pain during treatment in the intensive care ward.

    This medicinal product is intended to be used in hospitals.

    ATC code: N01AH06